Product Overview
The DRI® Cocaine Metabolite Assay is a homogeneous enzyme immunoassay intended for the qualitative and/or semi-quantitative determination of benzoylecgonine (Cocaine Metabolite) in human urine at a cutoff concentration of either 150 ng/mL or 300 ng/mL.
Product Features
- Designed for the qualitative detection of cocaine and its metabolites in urine.
- Compatible with MedTest 200, 480, and 800 ensemble systems.
- Contains 100 ml of testing solution per box of two.
- Easy-to-use format facilitates quick and efficient testing.
- High sensitivity and specificity to minimize false positives and negatives.
Product Specifications
| Catalog Number/SKU | MF-5390012210 |
| Application | Toxicology Reagent |
|---|---|
| For Use With | For MedTest 200 Ensemble, 480 Ensemble and 800 Ensemble Systems |
| Form | Ready-to-Use Liquid |
| Sample Type | Urine Sample |
| Specialty | Toxicology |
| Storage Requirements | Requires Refrigeration |
| Test Category | Drugs of Abuse |
| Test Method | Homogeneous Enzyme Immunoassay (HEIA) |
| Test Name | Cocaine (COC) |
| Test Type | Single Drug |
| Volume | 2 X 100 mL |
